Loading…
Sectoral / Thematic · Mirae Asset Mutual Fund · AMFI code 143783Mirae Asset Healthcare Fund
Disclosed for 70 months, Jan 2021 to Oct 2026.
Portfolio value
₹3,562 Cr
up ₹67.8 Cr vs Sep 2026
- Stocks held
- 28
- 1 vs Sep 2026
Holdings as of the end of October 2026, from Mirae Asset Mutual Fund’s monthly portfolio disclosure. Fund houses publish each month’s portfolio within 10 days of the month end, and this page is updated after they do. How the data is checked
Mirae Asset Healthcare Fund is an active equity fund in the Sectoral / Thematic category from Mirae Asset Mutual Fund. In October 2026 it disclosed 28 stocks worth ₹3,562 Cr, up ₹67.8 Cr from Sep 2026. Its largest positions were Sun Pharmaceutical Industries Limited (10.3%), Divi's Laboratories Limited (10.0%), Torrent Pharmaceuticals Limited (6.4%); the ten largest together made up 59.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.0% of its equity. Cash and debt stood at 0.1%. Compared with Sep 2026 the fund entered 0 new stocks and exited 1.
Against 234 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
1%
Holds more cash than 1% of peers
What these mean: concentration · cash
Holdings in October 2026
Download CSVEvery line the fund disclosed, with the change against Sep 2026. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 10.32% | up 0.17 pts | ₹367 Cr | up ₹12.8 Cr | Added |
| Divi's Laboratories Limited | 9.97% | up 0.18 pts | ₹355 Cr | up ₹13.1 Cr | Added |
| Torrent Pharmaceuticals Limited | 6.41% | down 0.39 pts | ₹228 Cr | down ₹9.2 Cr | Trimmed |
| Laurus Labs Limited | 6.37% | up 0.85 pts | ₹227 Cr | up ₹34.2 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.81% | up 0.19 pts | ₹207 Cr | up ₹10.5 Cr | Added |
| Dr. Reddy's Laboratories Limited | 5.45% | up 0.61 pts | ₹194 Cr | up ₹25.1 Cr | Added |
| Glenmark Pharmaceuticals Limited | 4.61% | down 0.16 pts | ₹164 Cr | down ₹2.6 Cr | Trimmed |
| Aurobindo Pharma Limited | 3.73% | down 0.05 pts | ₹133 Cr | up ₹74 L | Added |
| Alkem Laboratories Limited | 3.65% | down 0.11 pts | ₹130 Cr | down ₹1.3 Cr | Trimmed |
| Krishna Institute Of Medical Sciences Limited | 3.48% | up 0.09 pts | ₹124 Cr | up ₹5.6 Cr | Added |
| IPCA Laboratories Limited | 3.33% | down 0.06 pts | ₹118 Cr | up ₹5 L | Held |
| Sai Life Sciences Limited | 3.23% | up 0.01 pts | ₹115 Cr | up ₹2.4 Cr | Added |
| Aster DM Healthcare Limited | 3.19% | down 0.14 pts | ₹114 Cr | down ₹2.7 Cr | Trimmed |
| Dr. Lal Path Labs Limited | 3.05% | up 0.15 pts | ₹109 Cr | up ₹7.3 Cr | Added |
| Onesource Specialty Pharma Limited | 3.04% | up 0.02 pts | ₹108 Cr | up ₹2.9 Cr | Added |
| Fortis Healthcare Limited | 2.87% | down 0.06 pts | ₹102 Cr | down ₹25 L | Held |
| Gland Pharma Limited | 2.82% | up 0.13 pts | ₹100 Cr | up ₹6.4 Cr | Added |
| Cipla Limited | 2.65% | up 0.01 pts | ₹94.3 Cr | up ₹2.2 Cr | Added |
| Eris Lifesciences Limited | 2.27% | down 0.12 pts | ₹80.9 Cr | down ₹2.5 Cr | Trimmed |
| Lupin Limited | 2.20% | down 0.06 pts | ₹78.5 Cr | down ₹75 L | Trimmed |
| Mankind Pharma Limited | 2.19% | down 0.05 pts | ₹78 Cr | down ₹34 L | Held |
| Max Healthcare Institute Limited | 2.13% | down 0.22 pts | ₹75.8 Cr | down ₹6.2 Cr | Trimmed |
| Biocon Limited | 1.97% | down 0.04 pts | ₹70.1 Cr | up ₹2 L | Held |
| Molbio Diagnostics Ltd. | 1.69% | down 0.08 pts | ₹60.2 Cr | down ₹1.7 Cr | Trimmed |
| Symbiotec Pharmalab Limited | 1.66% | up 0.06 pts | ₹59.1 Cr | up ₹3.3 Cr | Added |
| Neogen Chemicals Ltd. | 1.41% | down 0.09 pts | ₹50.2 Cr | down ₹2.3 Cr | Trimmed |
| Deepak Nitrite Limited | 0.39% | down 0.01 pts | ₹13.9 Cr | down ₹10 L | Trimmed |
| Cash, TREPS & receivables | 0.12% | up 0.09 pts | ₹4.1 Cr | up ₹3.4 Cr | Added |
| Mirae Asset Cash Management Fund - DIRECT GROWTH Fund units | 0.01% | down <0.01 pts | ₹25 L | up ₹0 L | Held |
| Narayana Hrudayalaya Limited | <0.01% | down <0.01 pts | ₹3 L | down ₹0 L | Trimmed |
What changed, Sep 2026 to Oct 2026
New New positions (0)
None.
Exited Exited (1)
- Anthem Biosciences Limitedwas 0.9% · ₹32.5 Cr
Added Biggest additions
- Laurus Labs Limitedup ₹34.2 Cr (+0.85% pts)
- Dr. Reddy's Laboratories Limitedup ₹25.1 Cr (+0.61% pts)
- Divi's Laboratories Limitedup ₹13.1 Cr (+0.18% pts)
- Sun Pharmaceutical Industries Limitedup ₹12.8 Cr (+0.17% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2026, the weight rose most in Pharmaceuticals & Biotechnology (+0.1 pts), and fell most in Chemicals & Petrochemicals (−0.1 pts).
- Pharmaceuticals & Biotechnology75.8% → 76.0%+0.1 pts
- Chemicals & Petrochemicals1.9% → 1.8%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2023 | Oct 2025 | Apr 2026 | Jul 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 73.9% | 79.2% | 76.2% | 75.7% | 75.8% | 76.0% |
| Healthcare Services | 20.4% | 18.4% | 22.2% | 23.2% | 20.5% | 20.6% |
| Chemicals & Petrochemicals | 2.8% | 1.3% | 1.6% | 1.1% | 1.9% | 1.8% |
| Healthcare Equipment & Supplies | — | 0.5% | — | — | 1.8% | 1.7% |
Allocation in Oct 2026change vs Sep 2026
- Pharmaceuticals & Biotechnology (18)76.0%▲ 0.1 pts
- Healthcare Services (7)20.6%
- Chemicals & Petrochemicals (2)1.8%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Oct 2026
0.1%
▲ 0.1 pts vs Sep 2026
- Cash alone
- 0.1%
- cash and net receivables
- A year earlier
- 0.7%
- Oct 2025 · now ▼ 0.6 pts
- Last 12 months
- <0.1% – 1.2%
- lowest to highest · record 2.3% in Apr 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.